Towatari M - Search Results

1

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Towatari M, Yanada M, Usui N, Takeuchi J, Sugiura I, Takeuchi M, Yagasaki F, Kawai Y, Miyawaki S, Ohtake S, Jinnai I, Matsuo K, Naoe T, Ohno R; Japan Adult Leukemia Study Group. Towatari M, et al. Blood. 2004 Dec 1;104(12):3507-12. doi: 10.1182/blood-2004-04-1389. Epub 2004 Aug 17. Blood. 2004. PMID: 15315963 Free article. Clinical Trial.

2

Prognostic significance of the cell cycle inhibitor p27Kip1 in acute myeloid leukemia.

Yokozawa T, Towatari M, Iida H, Takeyama K, Tanimoto M, Kiyoi H, Motoji T, Asou N, Saito K, Takeuchi M, Kobayashi Y, Miyawaki S, Kodera Y, Ohno R, Saito H, Naoe T. Yokozawa T, et al. Among authors: towatari m. Leukemia. 2000 Jan;14(1):28-33. doi: 10.1038/sj.leu.2401640. Leukemia. 2000. PMID: 10637473

3

Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells.

Murata M, Towatari M, Kosugi H, Tanimoto M, Ueda R, Saito H, Naoe T. Murata M, et al. Among authors: towatari m. Jpn J Cancer Res. 2000 Nov;91(11):1154-60. doi: 10.1111/j.1349-7006.2000.tb00899.x. Jpn J Cancer Res. 2000. PMID: 11092981 Free PMC article.

4

Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product.

Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, Naoe T. Kiyoi H, et al. Among authors: towatari m. Leukemia. 1998 Sep;12(9):1333-7. doi: 10.1038/sj.leu.2401130. Leukemia. 1998. PMID: 9737679

5

In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice.

Kosugi H, Ito M, Yamamoto Y, Towatari M, Ito M, Ueda R, Saito H, Naoe T. Kosugi H, et al. Among authors: towatari m. Jpn J Cancer Res. 2001 May;92(5):529-36. doi: 10.1111/j.1349-7006.2001.tb01126.x. Jpn J Cancer Res. 2001. PMID: 11376562 Free PMC article.

6

Lyn is an important component of the signal transduction pathway specific to FLT3/ITD and can be a therapeutic target in the treatment of AML with FLT3/ITD.

Okamoto M, Hayakawa F, Miyata Y, Watamoto K, Emi N, Abe A, Kiyoi H, Towatari M, Naoe T. Okamoto M, et al. Among authors: towatari m. Leukemia. 2007 Mar;21(3):403-10. doi: 10.1038/sj.leu.2404547. Epub 2007 Jan 18. Leukemia. 2007. PMID: 17230226

7

Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation.

Watamoto K, Towatari M, Ozawa Y, Miyata Y, Okamoto M, Abe A, Naoe T, Saito H. Watamoto K, et al. Among authors: towatari m. Oncogene. 2003 Dec 11;22(57):9176-84. doi: 10.1038/sj.onc.1206902. Oncogene. 2003. PMID: 14668799

8

Overexpression of cyclin E in acute myelogenous leukemia.

Iida H, Towatari M, Tanimoto M, Morishita Y, Kodera Y, Saito H. Iida H, et al. Among authors: towatari m. Blood. 1997 Nov 1;90(9):3707-13. Blood. 1997. PMID: 9345056 Free article.

9

Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation.

Iida M, Towatari M, Nakao A, Iida H, Kiyoi H, Nakano Y, Tanimoto M, Saito H, Naoe T. Iida M, et al. Among authors: towatari m. Leukemia. 1999 Apr;13(4):585-9. doi: 10.1038/sj.leu.2401369. Leukemia. 1999. PMID: 10214865

10

In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor.

Zhao M, Kiyoi H, Yamamoto Y, Ito M, Towatari M, Omura S, Kitamura T, Ueda R, Saito H, Naoe T. Zhao M, et al. Among authors: towatari m. Leukemia. 2000 Mar;14(3):374-8. doi: 10.1038/sj.leu.2401680. Leukemia. 2000. PMID: 10720129

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters